BioMed Realty (BMR) Tops Q1 FFO by 2c; Revises FY10 Guidance
Tweet Send to a Friend
BioMed Realty (NYSE: BMR) reports Q1 FFO of $0.33, 2 cents better than the analyst estimate of $0.31. Revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
